{"transactions":[{"id":704212,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-07-23T20:38:54.000Z","date":"2026-07-22","kind":"grant","planned":false,"acquired":true,"shares":2380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Annual non-employee director award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders."}],"balance_after":2380,"derivative":{"exercise_price":527.07,"exercise_date":"2027-06-25","expiration_date":"2033-07-22","underlying":"Common Stock","underlying_shares":2380},"source":{"system":"sec-edgar","filing":"0001193522-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000119352226000002/primarydocument.xml","form_type":"4"}},{"id":710815,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-07-13T20:34:55.000Z","date":"2026-07-09","kind":"exercise","planned":false,"acquired":false,"shares":650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Shares received upon vesting of restricted stock units on July 9, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received upon vesting of restricted stock units on July 9, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares received upon vesting of restricted stock units on July 9, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not applicable as restricted stock units do not have an expiration date."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2026-07-09","underlying":"Common Stock","underlying_shares":650},"source":{"system":"sec-edgar","filing":"0001193522-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000119352226000001/primarydocument.xml","form_type":"4"}},{"id":710814,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-13T20:34:55.000Z","date":"2026-07-09","kind":"exercise","planned":false,"acquired":true,"shares":650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received upon vesting of restricted stock units on July 9, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares received upon vesting of restricted stock units on July 9, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock."}],"balance_after":2983,"source":{"system":"sec-edgar","filing":"0001193522-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000119352226000001/primarydocument.xml","form_type":"4"}},{"id":960118,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-12-23T21:33:38.000Z","date":"2025-12-22","kind":"exercise","planned":false,"acquired":false,"shares":2720,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held indirectly by a trust over which the reporting person has sole investment power and sole voting power."}],"balance_after":1840,"derivative":{"exercise_price":229.81,"exercise_date":"2024-07-13","expiration_date":"2033-07-13","underlying":"Common Stock","underlying_shares":2720},"source":{"system":"sec-edgar","filing":"0001193522-25-000004","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000119352225000004/primarydocument.xml","form_type":"4"}},{"id":960117,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-12-23T21:33:38.000Z","date":"2025-12-22","kind":"exercise","planned":false,"acquired":false,"shares":3230,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held indirectly by a trust over which the reporting person has sole investment power and sole voting power."}],"balance_after":0,"derivative":{"exercise_price":183.98,"exercise_date":"2022-07-08","expiration_date":"2031-07-08","underlying":"Common Stock","underlying_shares":3230},"source":{"system":"sec-edgar","filing":"0001193522-25-000004","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000119352225000004/primarydocument.xml","form_type":"4"}},{"id":960116,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-23T21:33:38.000Z","date":"2025-12-22","kind":"sale","planned":false,"acquired":false,"shares":4863,"price":512.3383,"value":2491501.1529,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $511.67 to $512.64. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held indirectly by a trust over which the reporting person has sole investment power and sole voting power."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193522-25-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000119352225000004/primarydocument.xml","form_type":"4"}},{"id":960115,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-23T21:33:38.000Z","date":"2025-12-22","kind":"sale","planned":false,"acquired":false,"shares":1087,"price":511.2231,"value":555699.5097,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $510.64 to $511.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held indirectly by a trust over which the reporting person has sole investment power and sole voting power."}],"balance_after":4863,"source":{"system":"sec-edgar","filing":"0001193522-25-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000119352225000004/primarydocument.xml","form_type":"4"}},{"id":960114,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-23T21:33:38.000Z","date":"2025-12-22","kind":"exercise","planned":false,"acquired":true,"shares":2720,"price":229.81,"value":625083.2,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held indirectly by a trust over which the reporting person has sole investment power and sole voting power."}],"balance_after":5950,"source":{"system":"sec-edgar","filing":"0001193522-25-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000119352225000004/primarydocument.xml","form_type":"4"}},{"id":960113,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-23T21:33:38.000Z","date":"2025-12-22","kind":"exercise","planned":false,"acquired":true,"shares":3230,"price":183.98,"value":594255.4,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held indirectly by a trust over which the reporting person has sole investment power and sole voting power."}],"balance_after":3230,"source":{"system":"sec-edgar","filing":"0001193522-25-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000119352225000004/primarydocument.xml","form_type":"4"}},{"id":1080850,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-07-28T10:21:46.000Z","date":"2025-07-24","kind":"grant","planned":false,"acquired":true,"shares":1830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Annual non-employee director award."}],"balance_after":1830,"derivative":{"exercise_price":306.41,"exercise_date":"2026-07-09","expiration_date":"2035-07-24","underlying":"Common Stock","underlying_shares":1830},"source":{"system":"sec-edgar","filing":"0001562180-25-005524","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218025005524/primarydocument.xml","form_type":"4"}},{"id":1080849,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-07-28T10:21:46.000Z","date":"2025-07-24","kind":"grant","planned":false,"acquired":true,"shares":650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock."},{"field":"shares","element":"transactionShares","label":"F6","text":"Annual non-employee director award."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not applicable as restricted stock units do not have an expiration date."}],"balance_after":650,"derivative":{"exercise_price":0,"exercise_date":"2026-07-09","underlying":"Common Stock","underlying_shares":650},"source":{"system":"sec-edgar","filing":"0001562180-25-005524","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218025005524/primarydocument.xml","form_type":"4"}},{"id":1080848,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-07-28T10:21:46.000Z","date":"2025-07-25","kind":"exercise","planned":false,"acquired":false,"shares":590,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not applicable as restricted stock units do not have an expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These restricted stock units were held  indirectly by a trust over which the reporting person has sole investment power and sole voting power."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2025-07-25","underlying":"Common Stock","underlying_shares":590},"source":{"system":"sec-edgar","filing":"0001562180-25-005524","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218025005524/primarydocument.xml","form_type":"4"}},{"id":1080847,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-28T10:21:46.000Z","date":"2025-07-25","kind":"exercise","planned":false,"acquired":true,"shares":590,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These common stock shares are held indirectly by a trust over which the reporting person has sole investment power and sole voting power."}],"balance_after":590,"source":{"system":"sec-edgar","filing":"0001562180-25-005524","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218025005524/primarydocument.xml","form_type":"4"}},{"id":1160899,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-03T00:30:17.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":15824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":41572,"derivative":{"exercise_price":5.45,"expiration_date":"2032-04-29","underlying":"Common Stock","underlying_shares":15824},"source":{"system":"sec-edgar","filing":"0001367644-25-000103","document":"wk-form4_1746232211.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1193522/000136764425000103/wk-form4_1746232211.xml","form_type":"4"}},{"id":1160898,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-03T00:30:17.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":34403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual grant of restricted stock units (\"RSUs\") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the \"Company\") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date (\"Annual Grant Vesting Date\"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date."}],"balance_after":139098,"source":{"system":"sec-edgar","filing":"0001367644-25-000103","document":"wk-form4_1746232211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1193522/000136764425000103/wk-form4_1746232211.xml","form_type":"4"}},{"id":1325742,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-12-19T21:30:48.000Z","date":"2024-12-18","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":175.43,"exercise_date":"2016-06-26","expiration_date":"2025-06-26","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001562180-24-008520","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218024008520/primarydocument.xml","form_type":"4"}},{"id":1325741,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-19T21:30:48.000Z","date":"2024-12-19","kind":"gift","planned":false,"acquired":false,"shares":1851,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3200,"source":{"system":"sec-edgar","filing":"0001562180-24-008520","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218024008520/primarydocument.xml","form_type":"4"}},{"id":1325740,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-19T21:30:48.000Z","date":"2024-12-18","kind":"sale","planned":false,"acquired":false,"shares":100,"price":382.245,"value":38224.5,"ownership":{"direct":true},"balance_after":5051,"source":{"system":"sec-edgar","filing":"0001562180-24-008520","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218024008520/primarydocument.xml","form_type":"4"}},{"id":1325739,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-19T21:30:48.000Z","date":"2024-12-18","kind":"sale","planned":false,"acquired":false,"shares":800,"price":381.3738,"value":305099.04,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F19","text":"This transaction was executed in multiple trades at prices ranging from $380.88 to $381.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":5151,"source":{"system":"sec-edgar","filing":"0001562180-24-008520","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218024008520/primarydocument.xml","form_type":"4"}},{"id":1325738,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-19T21:30:48.000Z","date":"2024-12-18","kind":"sale","planned":false,"acquired":false,"shares":944,"price":379.6741,"value":358412.3504,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F18","text":"This transaction was executed in multiple trades at prices ranging from $379.36 to $380.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":5951,"source":{"system":"sec-edgar","filing":"0001562180-24-008520","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218024008520/primarydocument.xml","form_type":"4"}},{"id":1325737,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-19T21:30:48.000Z","date":"2024-12-18","kind":"sale","planned":false,"acquired":false,"shares":400,"price":377.46,"value":150984.0,"ownership":{"direct":true},"balance_after":6895,"source":{"system":"sec-edgar","filing":"0001562180-24-008520","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218024008520/primarydocument.xml","form_type":"4"}},{"id":1325736,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-19T21:30:48.000Z","date":"2024-12-18","kind":"sale","planned":false,"acquired":false,"shares":2700,"price":375.03,"value":1012581.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F17","text":"This transaction was executed in multiple trades at prices ranging from $374.83 to $375.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":7295,"source":{"system":"sec-edgar","filing":"0001562180-24-008520","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218024008520/primarydocument.xml","form_type":"4"}},{"id":1325735,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-19T21:30:48.000Z","date":"2024-12-18","kind":"sale","planned":false,"acquired":false,"shares":1962,"price":374.1667,"value":734115.0654,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F16","text":"This transaction was executed in multiple trades at prices ranging from $373.70 to $374.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":9995,"source":{"system":"sec-edgar","filing":"0001562180-24-008520","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218024008520/primarydocument.xml","form_type":"4"}},{"id":1325734,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-19T21:30:48.000Z","date":"2024-12-18","kind":"sale","planned":false,"acquired":false,"shares":1525,"price":373.0584,"value":568914.06,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F15","text":"This transaction was executed in multiple trades at prices ranging from $372.55 to $373.395. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":11957,"source":{"system":"sec-edgar","filing":"0001562180-24-008520","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218024008520/primarydocument.xml","form_type":"4"}},{"id":1325733,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-19T21:30:48.000Z","date":"2024-12-18","kind":"sale","planned":false,"acquired":false,"shares":100,"price":370.78,"value":37078.0,"ownership":{"direct":true},"balance_after":13482,"source":{"system":"sec-edgar","filing":"0001562180-24-008520","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218024008520/primarydocument.xml","form_type":"4"}},{"id":1325732,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-19T21:30:48.000Z","date":"2024-12-18","kind":"sale","planned":false,"acquired":false,"shares":1926,"price":370.0152,"value":712649.2752,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F14","text":"This transaction was executed in multiple trades at prices ranging from $369.49 to $370.475. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":13582,"source":{"system":"sec-edgar","filing":"0001562180-24-008520","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218024008520/primarydocument.xml","form_type":"4"}},{"id":1325731,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-19T21:30:48.000Z","date":"2024-12-18","kind":"sale","planned":false,"acquired":false,"shares":752,"price":368.6682,"value":277238.4864,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F13","text":"This transaction was executed in multiple trades at prices ranging from $368.49 to $369.355. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":15508,"source":{"system":"sec-edgar","filing":"0001562180-24-008520","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218024008520/primarydocument.xml","form_type":"4"}},{"id":1325730,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-19T21:30:48.000Z","date":"2024-12-18","kind":"sale","planned":false,"acquired":false,"shares":100,"price":382.63,"value":38263.0,"ownership":{"direct":true},"balance_after":16260,"source":{"system":"sec-edgar","filing":"0001562180-24-008520","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218024008520/primarydocument.xml","form_type":"4"}},{"id":1325729,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-19T21:30:48.000Z","date":"2024-12-18","kind":"sale","planned":false,"acquired":false,"shares":620,"price":381.4105,"value":236474.51,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F12","text":"This transaction was executed in multiple trades at prices ranging from $381.205 to $381.645. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":16360,"source":{"system":"sec-edgar","filing":"0001562180-24-008520","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218024008520/primarydocument.xml","form_type":"4"}},{"id":1325728,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-19T21:30:48.000Z","date":"2024-12-18","kind":"sale","planned":false,"acquired":false,"shares":700,"price":380.12,"value":266084.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"This transaction was executed in multiple trades at prices ranging from $380.10 to $380.135. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":16980,"source":{"system":"sec-edgar","filing":"0001562180-24-008520","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218024008520/primarydocument.xml","form_type":"4"}},{"id":1325727,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-19T21:30:48.000Z","date":"2024-12-18","kind":"sale","planned":false,"acquired":false,"shares":200,"price":379.3,"value":75860.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"This transaction was executed in multiple trades at prices ranging from $378.91 to $379.69. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":17680,"source":{"system":"sec-edgar","filing":"0001562180-24-008520","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218024008520/primarydocument.xml","form_type":"4"}},{"id":1325726,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-19T21:30:48.000Z","date":"2024-12-18","kind":"sale","planned":false,"acquired":false,"shares":500,"price":374.4554,"value":187227.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This transaction was executed in multiple trades at prices ranging from $377.16 to $378.065. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":17880,"source":{"system":"sec-edgar","filing":"0001562180-24-008520","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218024008520/primarydocument.xml","form_type":"4"}},{"id":1325725,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-19T21:30:48.000Z","date":"2024-12-18","kind":"sale","planned":false,"acquired":false,"shares":2200,"price":375.003,"value":825006.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $374.82 to $375.48. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":18380,"source":{"system":"sec-edgar","filing":"0001562180-24-008520","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218024008520/primarydocument.xml","form_type":"4"}},{"id":1325724,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-19T21:30:48.000Z","date":"2024-12-18","kind":"sale","planned":false,"acquired":false,"shares":2451,"price":374.1363,"value":917008.0713,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $373.70 to $374.585. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":20580,"source":{"system":"sec-edgar","filing":"0001562180-24-008520","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218024008520/primarydocument.xml","form_type":"4"}},{"id":1325723,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-19T21:30:48.000Z","date":"2024-12-18","kind":"sale","planned":false,"acquired":false,"shares":200,"price":371.245,"value":74249.0,"ownership":{"direct":true},"balance_after":23031,"source":{"system":"sec-edgar","filing":"0001562180-24-008520","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218024008520/primarydocument.xml","form_type":"4"}},{"id":1325722,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-19T21:30:48.000Z","date":"2024-12-18","kind":"sale","planned":false,"acquired":false,"shares":1501,"price":373.1167,"value":560048.1667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $372.52 to $373.36. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":23231,"source":{"system":"sec-edgar","filing":"0001562180-24-008520","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218024008520/primarydocument.xml","form_type":"4"}},{"id":1325721,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-19T21:30:48.000Z","date":"2024-12-18","kind":"sale","planned":false,"acquired":false,"shares":1400,"price":370.295,"value":518413.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $369.95 to $370.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":24732,"source":{"system":"sec-edgar","filing":"0001562180-24-008520","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218024008520/primarydocument.xml","form_type":"4"}},{"id":1325720,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-19T21:30:48.000Z","date":"2024-12-18","kind":"sale","planned":false,"acquired":false,"shares":2100,"price":369.3155,"value":775562.55,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $368.90 to $369.68. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":26132,"source":{"system":"sec-edgar","filing":"0001562180-24-008520","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218024008520/primarydocument.xml","form_type":"4"}},{"id":1325719,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-19T21:30:48.000Z","date":"2024-12-18","kind":"sale","planned":false,"acquired":false,"shares":1307,"price":368.502,"value":481632.114,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $367.87 to $368.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":28232,"source":{"system":"sec-edgar","filing":"0001562180-24-008520","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218024008520/primarydocument.xml","form_type":"4"}},{"id":1325718,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-19T21:30:48.000Z","date":"2024-12-18","kind":"sale","planned":false,"acquired":false,"shares":600,"price":366.9725,"value":220183.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $366.545 to $367.37. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":29539,"source":{"system":"sec-edgar","filing":"0001562180-24-008520","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218024008520/primarydocument.xml","form_type":"4"}},{"id":1325717,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-19T21:30:48.000Z","date":"2024-12-18","kind":"sale","planned":false,"acquired":false,"shares":1121,"price":366.1077,"value":410406.7317,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $365.475 to $366.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":30139,"source":{"system":"sec-edgar","filing":"0001562180-24-008520","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218024008520/primarydocument.xml","form_type":"4"}},{"id":1325716,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-19T21:30:48.000Z","date":"2024-12-18","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":175.43,"value":2631450.0,"ownership":{"direct":true},"balance_after":31260,"source":{"system":"sec-edgar","filing":"0001562180-24-008520","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218024008520/primarydocument.xml","form_type":"4"}},{"id":1448251,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-07-26T20:30:25.000Z","date":"2024-07-25","kind":"grant","planned":false,"acquired":true,"shares":590,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"Annual non-employee director award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These awards vest on the one-year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Not applicable as restricted stock units do not have an expiration date."}],"balance_after":590,"derivative":{"exercise_price":0,"exercise_date":"2025-07-25","underlying":"Common Stock","underlying_shares":590},"source":{"system":"sec-edgar","filing":"0001415889-24-020169","document":"form4-07262024_040719.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588924020169/form4-07262024_040719.xml","form_type":"4"}},{"id":1448250,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-07-26T20:30:25.000Z","date":"2024-07-25","kind":"grant","planned":false,"acquired":true,"shares":1440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual non-employee director award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These awards vest on the one-year anniversary of the grant date."}],"balance_after":1440,"derivative":{"exercise_price":336.37,"exercise_date":"2025-07-25","expiration_date":"2034-07-25","underlying":"Common Stock","underlying_shares":1440},"source":{"system":"sec-edgar","filing":"0001415889-24-020169","document":"form4-07262024_040719.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588924020169/form4-07262024_040719.xml","form_type":"4"}},{"id":1500131,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-29T01:14:55.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":25748,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The number of options granted was determined by dividing half of the total non-employee director compensation value by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":25748,"derivative":{"exercise_price":5.02,"expiration_date":"2031-05-22","underlying":"Common Stock","underlying_shares":25748},"source":{"system":"sec-edgar","filing":"0001367644-24-000079","document":"wk-form4_1716945287.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1193522/000136764424000079/wk-form4_1716945287.xml","form_type":"4"}},{"id":1500130,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-29T01:14:55.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":17430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual grant of restricted stock units (\"RSUs\") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the \"Company\") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date (\"Annual Grant Vesting Date\"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date."}],"balance_after":104695,"source":{"system":"sec-edgar","filing":"0001367644-24-000079","document":"wk-form4_1716945287.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1193522/000136764424000079/wk-form4_1716945287.xml","form_type":"4"}},{"id":1526636,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-05-06T20:30:13.000Z","date":"2024-05-03","kind":"exercise","planned":false,"acquired":false,"shares":5160,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":119.76,"exercise_date":"2021-06-26","expiration_date":"2030-06-26","underlying":"Common Stock","underlying_shares":5160},"source":{"system":"sec-edgar","filing":"0001415889-24-012328","document":"form4-05062024_040501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588924012328/form4-05062024_040501.xml","form_type":"4"}},{"id":1526635,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-06T20:30:13.000Z","date":"2024-05-03","kind":"sale","planned":false,"acquired":false,"shares":2979,"price":259.1199,"value":771918.1821,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $258.49 to $259.395. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":13060,"source":{"system":"sec-edgar","filing":"0001415889-24-012328","document":"form4-05062024_040501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588924012328/form4-05062024_040501.xml","form_type":"4"}},{"id":1526634,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-06T20:30:13.000Z","date":"2024-05-03","kind":"sale","planned":false,"acquired":false,"shares":2181,"price":257.3895,"value":561366.4995,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $256.98 to $257.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":16039,"source":{"system":"sec-edgar","filing":"0001415889-24-012328","document":"form4-05062024_040501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588924012328/form4-05062024_040501.xml","form_type":"4"}},{"id":1526633,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-06T20:30:13.000Z","date":"2024-05-03","kind":"exercise","planned":false,"acquired":true,"shares":5160,"price":119.76,"value":617961.6,"ownership":{"direct":true},"balance_after":18220,"source":{"system":"sec-edgar","filing":"0001415889-24-012328","document":"form4-05062024_040501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588924012328/form4-05062024_040501.xml","form_type":"4"}},{"id":1828967,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-07-17T10:30:17.000Z","date":"2023-07-13","kind":"grant","planned":false,"acquired":true,"shares":4560,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual non-employee director award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These awards vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders."}],"balance_after":4560,"derivative":{"exercise_price":229.81,"exercise_date":"2024-07-13","expiration_date":"2033-07-13","underlying":"Common Stock","underlying_shares":4560},"source":{"system":"sec-edgar","filing":"0001415889-23-011152","document":"form4-07172023_060711.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588923011152/form4-07172023_060711.xml","form_type":"4"}},{"id":1833179,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-07-07T20:30:28.000Z","date":"2023-07-07","kind":"exercise","planned":false,"acquired":false,"shares":880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Shares received upon vesting of restricted stock units on July 7, 2023. Restricted stock units converted on a one-for-one basis into shares of common stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received upon vesting of restricted stock units on July 7, 2023. Restricted stock units converted on a one-for-one basis into shares of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Not applicable as restricted stock units do not have an expiration date."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2023-07-07","underlying":"Common Stock","underlying_shares":880},"source":{"system":"sec-edgar","filing":"0001415889-23-010952","document":"form4-07072023_040717.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588923010952/form4-07072023_040717.xml","form_type":"4"}},{"id":1833178,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-07T20:30:28.000Z","date":"2023-07-07","kind":"exercise","planned":false,"acquired":true,"shares":880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received upon vesting of restricted stock units on July 7, 2023. Restricted stock units converted on a one-for-one basis into shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares received upon vesting of restricted stock units on July 7, 2023. Restricted stock units converted on a one-for-one basis into shares of common stock."}],"balance_after":13060,"source":{"system":"sec-edgar","filing":"0001415889-23-010952","document":"form4-07072023_040717.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588923010952/form4-07072023_040717.xml","form_type":"4"}},{"id":1874481,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-30T23:07:26.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":33847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted under the company's Stock Incentive Plan, as amended and restated. These restricted stock units vest in one installment beginning on the day prior to the first anniversary of the date of grant assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":87265,"source":{"system":"sec-edgar","filing":"0001367644-23-000107","document":"wk-form4_1685488014.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1193522/000136764423000107/wk-form4_1685488014.xml","form_type":"4"}},{"id":1980704,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-03-02T21:30:48.000Z","date":"2023-03-01","kind":"exercise","acquired":false,"shares":700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person."}],"balance_after":0,"derivative":{"exercise_price":132.3,"exercise_date":"2018-06-28","expiration_date":"2027-06-28","underlying":"Common Stock","underlying_shares":700},"source":{"system":"sec-edgar","filing":"0001415889-23-003824","document":"form4-03022023_040329.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588923003824/form4-03022023_040329.xml","form_type":"4"}},{"id":1980703,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-02T21:30:48.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":700,"price":245.1,"value":171570.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person."}],"balance_after":12180,"source":{"system":"sec-edgar","filing":"0001415889-23-003824","document":"form4-03022023_040329.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588923003824/form4-03022023_040329.xml","form_type":"4"}},{"id":1980702,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-02T21:30:48.000Z","date":"2023-03-01","kind":"exercise","acquired":true,"shares":700,"price":132.3,"value":92610.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person."}],"balance_after":12880,"source":{"system":"sec-edgar","filing":"0001415889-23-003824","document":"form4-03022023_040329.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588923003824/form4-03022023_040329.xml","form_type":"4"}},{"id":2037024,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-02-02T21:30:18.000Z","date":"2023-02-01","kind":"exercise","acquired":false,"shares":700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person."}],"balance_after":700,"derivative":{"exercise_price":132.3,"exercise_date":"2018-06-28","expiration_date":"2027-06-28","underlying":"Common Stock","underlying_shares":700},"source":{"system":"sec-edgar","filing":"0001415889-23-001809","document":"form4-02022023_040201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588923001809/form4-02022023_040201.xml","form_type":"4"}},{"id":2037023,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-02T21:30:18.000Z","date":"2023-02-01","kind":"sale","acquired":false,"shares":700,"price":261.33,"value":182931.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person."}],"balance_after":12180,"source":{"system":"sec-edgar","filing":"0001415889-23-001809","document":"form4-02022023_040201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588923001809/form4-02022023_040201.xml","form_type":"4"}},{"id":2037022,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-02T21:30:18.000Z","date":"2023-02-01","kind":"exercise","acquired":true,"shares":700,"price":132.3,"value":92610.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person."}],"balance_after":12880,"source":{"system":"sec-edgar","filing":"0001415889-23-001809","document":"form4-02022023_040201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588923001809/form4-02022023_040201.xml","form_type":"4"}},{"id":2073218,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-01-03T22:20:09.000Z","date":"2023-01-03","kind":"exercise","acquired":false,"shares":700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person."}],"balance_after":1400,"derivative":{"exercise_price":132.3,"exercise_date":"2018-06-28","expiration_date":"2027-06-28","underlying":"Common Stock","underlying_shares":700},"source":{"system":"sec-edgar","filing":"0001415889-23-000105","document":"form4-01032023_100100.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588923000105/form4-01032023_100100.xml","form_type":"4"}},{"id":2073217,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-03T22:20:09.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":700,"price":276.26,"value":193382.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person."}],"balance_after":12180,"source":{"system":"sec-edgar","filing":"0001415889-23-000105","document":"form4-01032023_100100.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588923000105/form4-01032023_100100.xml","form_type":"4"}},{"id":2073216,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-03T22:20:09.000Z","date":"2023-01-03","kind":"exercise","acquired":false,"shares":700,"price":132.3,"value":92610.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person."}],"balance_after":12880,"source":{"system":"sec-edgar","filing":"0001415889-23-000105","document":"form4-01032023_100100.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588923000105/form4-01032023_100100.xml","form_type":"4"}},{"id":2100415,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-12-01T21:30:30.000Z","date":"2022-12-01","kind":"exercise","acquired":true,"shares":700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person."}],"balance_after":2100,"derivative":{"exercise_price":132.3,"exercise_date":"2018-06-28","expiration_date":"2027-06-28","underlying":"Common Stock","underlying_shares":700},"source":{"system":"sec-edgar","filing":"0001415889-22-011882","document":"form4-12012022_041214.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922011882/form4-12012022_041214.xml","form_type":"4"}},{"id":2100414,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-01T21:30:30.000Z","date":"2022-12-01","kind":"sale","acquired":false,"shares":700,"price":279.89,"value":195923.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person."}],"balance_after":12180,"source":{"system":"sec-edgar","filing":"0001415889-22-011882","document":"form4-12012022_041214.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922011882/form4-12012022_041214.xml","form_type":"4"}},{"id":2100413,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-01T21:30:30.000Z","date":"2022-12-01","kind":"exercise","acquired":true,"shares":700,"price":132.3,"value":92610.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person."}],"balance_after":12880,"source":{"system":"sec-edgar","filing":"0001415889-22-011882","document":"form4-12012022_041214.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922011882/form4-12012022_041214.xml","form_type":"4"}},{"id":2127506,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-11-02T20:30:13.000Z","date":"2022-11-01","kind":"exercise","acquired":false,"shares":700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person."}],"balance_after":2800,"derivative":{"exercise_price":132.3,"exercise_date":"2018-06-28","expiration_date":"2027-06-28","underlying":"Common Stock","underlying_shares":700},"source":{"system":"sec-edgar","filing":"0001415889-22-010999","document":"form4-11022022_041101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922010999/form4-11022022_041101.xml","form_type":"4"}},{"id":2127505,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-02T20:30:13.000Z","date":"2022-11-01","kind":"sale","acquired":false,"shares":700,"price":230.28,"value":161196.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person."}],"balance_after":12180,"source":{"system":"sec-edgar","filing":"0001415889-22-010999","document":"form4-11022022_041101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922010999/form4-11022022_041101.xml","form_type":"4"}},{"id":2127504,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-02T20:30:13.000Z","date":"2022-11-01","kind":"exercise","acquired":true,"shares":700,"price":132.3,"value":92610.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person."}],"balance_after":12880,"source":{"system":"sec-edgar","filing":"0001415889-22-010999","document":"form4-11022022_041101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922010999/form4-11022022_041101.xml","form_type":"4"}},{"id":2147867,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-10-03T20:34:36.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":710,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person."}],"balance_after":3500,"derivative":{"exercise_price":132.3,"exercise_date":"2018-06-28","expiration_date":"2027-06-28","underlying":"Common Stock","underlying_shares":710},"source":{"system":"sec-edgar","filing":"0001415889-22-010072","document":"form4-10032022_041009.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922010072/form4-10032022_041009.xml","form_type":"4"}},{"id":2147866,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-03T20:34:36.000Z","date":"2022-10-03","kind":"sale","acquired":false,"shares":710,"price":211.56,"value":150207.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person."}],"balance_after":12180,"source":{"system":"sec-edgar","filing":"0001415889-22-010072","document":"form4-10032022_041009.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922010072/form4-10032022_041009.xml","form_type":"4"}},{"id":2147865,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-03T20:34:36.000Z","date":"2022-10-03","kind":"exercise","acquired":true,"shares":710,"price":132.3,"value":93933.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person."}],"balance_after":12890,"source":{"system":"sec-edgar","filing":"0001415889-22-010072","document":"form4-10032022_041009.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922010072/form4-10032022_041009.xml","form_type":"4"}},{"id":2166354,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-09-06T20:30:35.000Z","date":"2022-09-02","kind":"exercise","acquired":false,"shares":4910,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":101.8,"exercise_date":"2017-06-21","expiration_date":"2026-06-21","underlying":"Common Stock","underlying_shares":4910},"source":{"system":"sec-edgar","filing":"0001415889-22-009375","document":"form4-09062022_040906.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922009375/form4-09062022_040906.xml","form_type":"4"}},{"id":2166353,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-06T20:30:35.000Z","date":"2022-09-02","kind":"sale","acquired":false,"shares":4910,"price":225.9776,"value":1109550.016,"ownership":{"direct":true},"balance_after":12180,"source":{"system":"sec-edgar","filing":"0001415889-22-009375","document":"form4-09062022_040906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922009375/form4-09062022_040906.xml","form_type":"4"}},{"id":2166352,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-06T20:30:35.000Z","date":"2022-09-02","kind":"exercise","acquired":true,"shares":4910,"price":101.8,"value":499838.0,"ownership":{"direct":true},"balance_after":17090,"source":{"system":"sec-edgar","filing":"0001415889-22-009375","document":"form4-09062022_040906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922009375/form4-09062022_040906.xml","form_type":"4"}},{"id":2209317,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-07-11T20:30:35.000Z","date":"2022-07-08","kind":"exercise","acquired":false,"shares":1080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"This amendment corrects an overstatement of the number of restricted stock units that vested on July 8, 2022, and the number of resulting shares of common stock received by the reporting person. In both cases, the original number reported (3,230 restricted stock units / shares of common stock) has been corrected (1,080 restricted stock units / shares of common stock)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2022-07-08","underlying":"Common Stock","underlying_shares":1080},"source":{"system":"sec-edgar","filing":"0001415889-22-007628","document":"form4a-07112022_040717.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922007628/form4a-07112022_040717.xml","form_type":"4/A","original_submission_date":"2022-07-08"}},{"id":2209316,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-11T20:30:35.000Z","date":"2022-07-08","kind":"exercise","acquired":true,"shares":1080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amendment corrects an overstatement of the number of restricted stock units that vested on July 8, 2022, and the number of resulting shares of common stock received by the reporting person. In both cases, the original number reported (3,230 restricted stock units / shares of common stock) has been corrected (1,080 restricted stock units / shares of common stock)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares received upon vesting of restricted stock units on July 8, 2022.  Restricted stock units converted on a one-for-one basis into shares of common stock."}],"balance_after":12180,"source":{"system":"sec-edgar","filing":"0001415889-22-007628","document":"form4a-07112022_040717.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922007628/form4a-07112022_040717.xml","form_type":"4/A","original_submission_date":"2022-07-08"}},{"id":2210150,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-07-08T21:42:58.000Z","date":"2022-07-07","kind":"grant","acquired":true,"shares":2490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Annual non-employee director award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders."}],"balance_after":2490,"derivative":{"exercise_price":240.2,"exercise_date":"2023-07-07","expiration_date":"2032-07-07","underlying":"Common Stock","underlying_shares":2490},"source":{"system":"sec-edgar","filing":"0001415889-22-007602","document":"form4-07082022_020747.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922007602/form4-07082022_020747.xml","form_type":"4"}},{"id":2210149,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-07-08T21:42:58.000Z","date":"2022-07-07","kind":"grant","acquired":true,"shares":880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"Annual non-employee director award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders."}],"balance_after":880,"derivative":{"exercise_price":0,"exercise_date":"2023-07-07","underlying":"Common Stock","underlying_shares":880},"source":{"system":"sec-edgar","filing":"0001415889-22-007602","document":"form4-07082022_020747.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922007602/form4-07082022_020747.xml","form_type":"4"}},{"id":2210148,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-07-08T21:42:58.000Z","date":"2022-07-08","kind":"exercise","acquired":false,"shares":3230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2022-07-08","underlying":"Common Stock","underlying_shares":3230},"source":{"system":"sec-edgar","filing":"0001415889-22-007602","document":"form4-07082022_020747.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922007602/form4-07082022_020747.xml","form_type":"4"}},{"id":2210147,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-08T21:42:58.000Z","date":"2022-07-08","kind":"exercise","acquired":true,"shares":3230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares received upon vesting of restricted stock units on July 8, 2022.  Restricted stock units converted on a one-for-one basis into shares of common stock"}],"balance_after":14330,"source":{"system":"sec-edgar","filing":"0001415889-22-007602","document":"form4-07082022_020747.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922007602/form4-07082022_020747.xml","form_type":"4"}},{"id":2251056,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-31T20:15:19.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":8446,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated."},{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company."}],"balance_after":53418,"source":{"system":"sec-edgar","filing":"0001367644-22-000089","document":"wf-form4_165402808228714.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1193522/000136764422000089/wf-form4_165402808228714.xml","form_type":"4"}},{"id":2255655,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-05-26T20:30:29.000Z","date":"2022-05-26","kind":"exercise","acquired":false,"shares":6310,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":76.36,"exercise_date":"2020-06-26","expiration_date":"2029-06-26","underlying":"Common Stock","underlying_shares":6310},"source":{"system":"sec-edgar","filing":"0001415889-22-005696","document":"form4-05262022_040510.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922005696/form4-05262022_040510.xml","form_type":"4"}},{"id":2255654,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-26T20:30:29.000Z","date":"2022-05-26","kind":"sale","acquired":false,"shares":1345,"price":226.7383,"value":304963.0135,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $226.50 to $226.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":11100,"source":{"system":"sec-edgar","filing":"0001415889-22-005696","document":"form4-05262022_040510.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922005696/form4-05262022_040510.xml","form_type":"4"}},{"id":2255653,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-26T20:30:29.000Z","date":"2022-05-26","kind":"sale","acquired":false,"shares":1500,"price":226.0419,"value":339062.85,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $225.48 to $226.19. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":12445,"source":{"system":"sec-edgar","filing":"0001415889-22-005696","document":"form4-05262022_040510.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922005696/form4-05262022_040510.xml","form_type":"4"}},{"id":2255652,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-26T20:30:29.000Z","date":"2022-05-26","kind":"sale","acquired":false,"shares":1766,"price":224.3771,"value":396249.9586,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $224.00 to $224.69. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":13945,"source":{"system":"sec-edgar","filing":"0001415889-22-005696","document":"form4-05262022_040510.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922005696/form4-05262022_040510.xml","form_type":"4"}},{"id":2255651,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-26T20:30:29.000Z","date":"2022-05-26","kind":"sale","acquired":false,"shares":1699,"price":223.37,"value":379505.63,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $222.94 to $223.82. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":15711,"source":{"system":"sec-edgar","filing":"0001415889-22-005696","document":"form4-05262022_040510.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922005696/form4-05262022_040510.xml","form_type":"4"}},{"id":2255650,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-26T20:30:29.000Z","date":"2022-05-26","kind":"exercise","acquired":true,"shares":6310,"price":76.36,"value":481831.6,"ownership":{"direct":true},"balance_after":17410,"source":{"system":"sec-edgar","filing":"0001415889-22-005696","document":"form4-05262022_040510.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922005696/form4-05262022_040510.xml","form_type":"4"}},{"id":2637255,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2021-07-09T21:00:58.000Z","date":"2021-07-08","kind":"grant","acquired":true,"shares":1080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"Annual non-employee director grant of restricted stock units, which are awarded each year on the date of the first board meeting following the issuer's Annual Meeting of Shareholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders."}],"balance_after":1080,"derivative":{"exercise_price":0,"exercise_date":"2022-07-08","underlying":"Common Stock","underlying_shares":1080},"source":{"system":"sec-edgar","filing":"0001127602-21-021766","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760221021766/form4.xml","form_type":"4"}},{"id":2637254,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true}}],"security":"Stock Options","published_at":"2021-07-09T21:00:58.000Z","date":"2021-07-08","kind":"grant","acquired":true,"shares":3230,"price":183.98,"value":594255.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual non-employee director grant of stock options, which are awarded and priced each year on the date of the first board meeting following the issuer's Annual Meeting of Shareholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders."}],"balance_after":3230,"derivative":{"exercise_price":183.98,"exercise_date":"2022-07-08","expiration_date":"2031-07-08","underlying":"Common Stock","underlying_shares":3230},"source":{"system":"sec-edgar","filing":"0001127602-21-021766","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760221021766/form4.xml","form_type":"4"}},{"id":2653976,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2021-06-28T22:17:23.000Z","date":"2021-06-26","kind":"exercise","acquired":false,"shares":1680,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares received upon vesting of restricted stock units on June 26, 2021. Restricted stock units converted on a one-for-one basis into shares of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Shares will be issued to the reporting person upon vesting unless the reporting person has elected to defer receipt of shares."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2021-06-26","underlying":"Common Stock","underlying_shares":1680},"source":{"system":"sec-edgar","filing":"0001127602-21-020758","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760221020758/form4.xml","form_type":"4"}},{"id":2653975,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-06-28T22:17:23.000Z","date":"2021-06-26","kind":"exercise","acquired":true,"shares":1680,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares received upon vesting of restricted stock units on June 26, 2021. Restricted stock units converted on a one-for-one basis into shares of common stock."}],"balance_after":11100,"source":{"system":"sec-edgar","filing":"0001127602-21-020758","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760221020758/form4.xml","form_type":"4"}},{"id":2698504,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-24T21:14:18.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":5027,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated."},{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company."}],"balance_after":44972,"source":{"system":"sec-edgar","filing":"0001367644-21-000097","document":"wf-form4_162189081830999.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1193522/000136764421000097/wf-form4_162189081830999.xml","form_type":"4"}},{"id":2717052,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true}}],"security":"Share Tracking Award","published_at":"2021-05-12T20:34:44.000Z","date":"2021-05-11","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":0,"derivative":{"exercise_price":88.03,"exercise_date":"2015-06-26","expiration_date":"2024-06-26","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001127602-21-016406","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760221016406/form4.xml","form_type":"4"}},{"id":2717051,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true}}],"security":"Share Tracking Award","published_at":"2021-05-12T20:34:44.000Z","date":"2021-05-11","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":0,"derivative":{"exercise_price":63.9,"exercise_date":"2014-06-26","expiration_date":"2023-06-26","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001127602-21-016406","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760221016406/form4.xml","form_type":"4"}},{"id":2717050,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-05-12T20:34:44.000Z","date":"2021-05-11","kind":"disposition_to_issuer","acquired":false,"shares":15000,"price":194.3,"value":2914500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":9420,"source":{"system":"sec-edgar","filing":"0001127602-21-016406","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760221016406/form4.xml","form_type":"4"}},{"id":2717049,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-05-12T20:34:44.000Z","date":"2021-05-11","kind":"exercise","acquired":true,"shares":15000,"price":88.03,"value":1320450.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":24420,"source":{"system":"sec-edgar","filing":"0001127602-21-016406","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760221016406/form4.xml","form_type":"4"}},{"id":2717048,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-05-12T20:34:44.000Z","date":"2021-05-11","kind":"disposition_to_issuer","acquired":false,"shares":15000,"price":194.3,"value":2914500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":9420,"source":{"system":"sec-edgar","filing":"0001127602-21-016406","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760221016406/form4.xml","form_type":"4"}},{"id":2717047,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-05-12T20:34:44.000Z","date":"2021-05-11","kind":"exercise","acquired":true,"shares":15000,"price":63.9,"value":958500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":24420,"source":{"system":"sec-edgar","filing":"0001127602-21-016406","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760221016406/form4.xml","form_type":"4"}},{"id":2718292,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":17426,"kind":"person","name":"SULLIVAN LOUIS W","position":1,"cik":"0001193522","reported_name":"SULLIVAN LOUIS W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2021-05-11T20:18:25.000Z","date":"2021-05-10","kind":"exercise","acquired":false,"shares":10305,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Consists of an option granted under the company's stock incentive plan as amended and restated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested in three equal installments in May 2015, May 2016 and May 2017. Each option represents the right of the reporting person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":0,"derivative":{"exercise_price":18.64,"exercise_date":"2017-05-21","expiration_date":"2021-05-21","underlying":"Common Stock","underlying_shares":10305},"source":{"system":"sec-edgar","filing":"0001367644-21-000075","document":"wf-form4_162076428587593.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1193522/000136764421000075/wf-form4_162076428587593.xml","form_type":"4"}}],"next_cursor":"2021-05-11T20:18:25.000000Z,2718292"}